A key intermediate of 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine and its preparation method
A compound and a range of technology, applied in the field of synthesis of pharmaceutical intermediates, can solve the problems of relatively high requirements on reaction conditions and unsuitability for industrial production, and achieve the effects of stable process, mild conditions and convenient purification
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043]Synthesis of compound III:
[0044]
[0045]Trimethylsilyl cyanide (140.88g, 1.42mol, 5.0eq) was dissolved in acetonitrile (300mL), compound II (50.00g, 0.284mol, 1.0eq) was added dropwise to it at 10°C, and finally at 30°C The reaction was stirred for 15 hours. LC-MS shows that the reaction is complete, spin dry the reaction solution, pour the residue into water, stir well, separate the liquids, extract the aqueous phase with DCM, combine the organic phases, wash with saturated NaCl solution, and separate the organic phase with anhydrous Mg2SO4After drying, the solvent was evaporated under reduced pressure to obtain 40.00 g of compound III as a brown solid, yield: 89.6%.
[0046]Synthesis of compound I:
[0047]
[0048]Compound III (40.00g, 0.254mol, 1.0e.q.) was dissolved in methanol (400mL), and SOCl was added dropwise2(151.32g, 1.27mol, 5.0e.q.), after the dropping is completed, the reaction is stirred at 40°C for 12 hours. TLC shows that the reaction is complete, the reaction solution ...
Embodiment 2
[0050]Synthesis of compound III:
[0051]
[0052]Trimethylsilyl cyanide (56.35g, 0.568mol, 2.0eq) was dissolved in acetonitrile (400mL), compound II (50.00g, 0.284mol, 1.0eq) was added dropwise to it at 10℃, and finally at 70℃ The reaction was stirred for 16 hours. LC-MS shows that the reaction is complete, spin dry the reaction solution, pour the residue into water, stir well, separate the liquids, extract the aqueous phase with DCM, combine the organic phases, wash with saturated NaCl solution, and separate the organic phase with anhydrous Mg2SO4After drying, the solvent was evaporated under reduced pressure to obtain 35.84 g of compound III as a brown solid, with a yield of 80.3%.
[0053]Synthesis of compound I:
[0054]
[0055]Compound III (35.84g, 0.228mo, 1.0e.q.) was dissolved in ethanol (500mL), and concentrated H was added dropwise2SO4(167.58g, 1.71mol, 7.5e.q.), after dripping, the reaction was stirred at 60°C for 14 hours. TLC shows that the reaction is complete, the reaction solutio...
Embodiment 3
[0057]Synthesis of compound III:
[0058]
[0059]Trimethylsilyl cyanide (281.76g, 2.84mol, 10.0eq) was dissolved in acetonitrile (400mL), compound II (50.00g, 0.284mol, 1.0eq) was added dropwise to it at 10°C, and finally at 10°C The reaction was stirred for 18 hours. LC-MS shows that the reaction is complete, spin dry the reaction solution, pour the residue into water, stir well, separate the liquids, extract the aqueous phase with DCM, combine the organic phases, wash with saturated NaCl solution, and separate the organic phase with anhydrous Mg2SO4After drying, the solvent was evaporated under reduced pressure to obtain 24.82 g of compound III as a brown solid, yield: 55.6%.
[0060]Synthesis of compound I-1:
[0061]
[0062]Compound III (24.82g, 0.158mol, 1.0e.q.) was dissolved in methanol (300mL), and SOCl was added dropwise2(189.15g, 1.59mol, 10.0e.q.), after the dropping is completed, the reaction is stirred at 60°C for 16 hours. TLC shows that the reaction is complete, the reaction solut...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
![A key intermediate of 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine and its preparation method](https://images-eureka.patsnap.com/patent_img/d3e4fdd2-17f4-4922-9b36-c5dfa08f6229/BDA0001514501430000011.png)
![A key intermediate of 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine and its preparation method](https://images-eureka.patsnap.com/patent_img/d3e4fdd2-17f4-4922-9b36-c5dfa08f6229/BDA0001514501430000012.png)
![A key intermediate of 6,7,8,9-tetrahydro-5h-pyrido[2,3-d]azepine and its preparation method](https://images-eureka.patsnap.com/patent_img/d3e4fdd2-17f4-4922-9b36-c5dfa08f6229/BDA0001514501430000021.png)